Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Liang Peng, Executive. Officer active across 1 company, notably Clover Biopharmaceuticals, Ltd. - B. Cumulatively, 17 reports have been published. History available since 13 March 2026. The latest transaction was disclosed on 16 July 2026 (Sale). Regulator: HKEX. All data is openly available.
Companies and markets linked to Liang Peng
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
500,000 shares@ HK$2.200.039% mcap28.4% of flowShareXHKGHKEX:DA20260318E00225
17 of 17 declarations
About Liang Peng
Liang Peng is an executive at Clover Biopharmaceuticals, Ltd. - B, a company specializing in the development of biopharmaceutical products. He plays a key role in the strategic direction of the company, focusing on innovation and research in the biopharmaceutical sector.